New Delhi, Sept. 10 -- The Indian Council of Medical Research (ICMR) has taken a major step forward in combating malaria by initiating the commercial rollout of its first indigenous multi-stage recombinant malaria vaccine,AdFalciVax.

Developed by ICMR's Regional Medical Research Centre in Bhubaneswar, with pre-clinical validation support from ICMR-National Institute of Malaria Research (NIMR) and the National Institute of Immunology, Delhi, this groundbreaking vaccine targetsPlasmodium falciparum. It aims not only to prevent infection but also to curb parasite transmission within communities.

In July, ICMR invited Expressions of Interest (EoI) from qualified manufacturers to facilitateTransfer of Technology (ToT)for further development,...